Cargando…
Plasma biomarker for detection of early stage pancreatic cancer and risk factors for pancreatic malignancy using antibodies for apolipoprotein-AII isoforms
We recently reported that circulating apolipoprotein AII (apoAII) isoforms apoAII-ATQ/AT (C-terminal truncations of the apoAII homo-dimer) decline significantly in pancreatic cancer and thus might serve as plasma biomarkers for the early detection of this disease. We report here the development of n...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4637825/ https://www.ncbi.nlm.nih.gov/pubmed/26549697 http://dx.doi.org/10.1038/srep15921 |
_version_ | 1782399834722926592 |
---|---|
author | Honda, Kazufumi Kobayashi, Michimoto Okusaka, Takuji Rinaudo, Jo Ann Huang, Ying Marsh, Tracey Sanada, Mitsuaki Sasajima, Yoshiyuki Nakamori, Shoji Shimahara, Masashi Ueno, Takaaki Tsuchida, Akihiko Sata, Naohiro Ioka, Tatsuya Yasunami, Yohichi Kosuge, Tomoo Miura, Nami Kamita, Masahiro Sakamoto, Takako Shoji, Hirokazu Jung, Giman Srivastava, Sudhir Yamada, Tesshi |
author_facet | Honda, Kazufumi Kobayashi, Michimoto Okusaka, Takuji Rinaudo, Jo Ann Huang, Ying Marsh, Tracey Sanada, Mitsuaki Sasajima, Yoshiyuki Nakamori, Shoji Shimahara, Masashi Ueno, Takaaki Tsuchida, Akihiko Sata, Naohiro Ioka, Tatsuya Yasunami, Yohichi Kosuge, Tomoo Miura, Nami Kamita, Masahiro Sakamoto, Takako Shoji, Hirokazu Jung, Giman Srivastava, Sudhir Yamada, Tesshi |
author_sort | Honda, Kazufumi |
collection | PubMed |
description | We recently reported that circulating apolipoprotein AII (apoAII) isoforms apoAII-ATQ/AT (C-terminal truncations of the apoAII homo-dimer) decline significantly in pancreatic cancer and thus might serve as plasma biomarkers for the early detection of this disease. We report here the development of novel enzyme-linked immunosorbent assays (ELISAs) for measurement of apoAII-ATQ/AT and their clinical applicability for early detection of pancreatic cancer. Plasma and serum concentrations of apoAII-ATQ/AT were measured in three independent cohorts, which comprised healthy control subjects and patients with pancreatic cancer and gastroenterologic diseases (n = 1156). These cohorts included 151 cases of stage I/II pancreatic cancer. ApoAII-ATQ/AT not only distinguished the early stages of pancreatic cancer from healthy controls but also identified patients at high risk for pancreatic malignancy. AUC values of apoAII-ATQ/AT to detect early stage pancreatic cancer were higher than those of CA19–9 in all independent cohorts. ApoAII-ATQ/AT is a potential biomarker for screening patients for the early stage of pancreatic cancer and identifying patients at risk for pancreatic malignancy (161 words). |
format | Online Article Text |
id | pubmed-4637825 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-46378252015-11-30 Plasma biomarker for detection of early stage pancreatic cancer and risk factors for pancreatic malignancy using antibodies for apolipoprotein-AII isoforms Honda, Kazufumi Kobayashi, Michimoto Okusaka, Takuji Rinaudo, Jo Ann Huang, Ying Marsh, Tracey Sanada, Mitsuaki Sasajima, Yoshiyuki Nakamori, Shoji Shimahara, Masashi Ueno, Takaaki Tsuchida, Akihiko Sata, Naohiro Ioka, Tatsuya Yasunami, Yohichi Kosuge, Tomoo Miura, Nami Kamita, Masahiro Sakamoto, Takako Shoji, Hirokazu Jung, Giman Srivastava, Sudhir Yamada, Tesshi Sci Rep Article We recently reported that circulating apolipoprotein AII (apoAII) isoforms apoAII-ATQ/AT (C-terminal truncations of the apoAII homo-dimer) decline significantly in pancreatic cancer and thus might serve as plasma biomarkers for the early detection of this disease. We report here the development of novel enzyme-linked immunosorbent assays (ELISAs) for measurement of apoAII-ATQ/AT and their clinical applicability for early detection of pancreatic cancer. Plasma and serum concentrations of apoAII-ATQ/AT were measured in three independent cohorts, which comprised healthy control subjects and patients with pancreatic cancer and gastroenterologic diseases (n = 1156). These cohorts included 151 cases of stage I/II pancreatic cancer. ApoAII-ATQ/AT not only distinguished the early stages of pancreatic cancer from healthy controls but also identified patients at high risk for pancreatic malignancy. AUC values of apoAII-ATQ/AT to detect early stage pancreatic cancer were higher than those of CA19–9 in all independent cohorts. ApoAII-ATQ/AT is a potential biomarker for screening patients for the early stage of pancreatic cancer and identifying patients at risk for pancreatic malignancy (161 words). Nature Publishing Group 2015-11-09 /pmc/articles/PMC4637825/ /pubmed/26549697 http://dx.doi.org/10.1038/srep15921 Text en Copyright © 2015, Macmillan Publishers Limited http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
spellingShingle | Article Honda, Kazufumi Kobayashi, Michimoto Okusaka, Takuji Rinaudo, Jo Ann Huang, Ying Marsh, Tracey Sanada, Mitsuaki Sasajima, Yoshiyuki Nakamori, Shoji Shimahara, Masashi Ueno, Takaaki Tsuchida, Akihiko Sata, Naohiro Ioka, Tatsuya Yasunami, Yohichi Kosuge, Tomoo Miura, Nami Kamita, Masahiro Sakamoto, Takako Shoji, Hirokazu Jung, Giman Srivastava, Sudhir Yamada, Tesshi Plasma biomarker for detection of early stage pancreatic cancer and risk factors for pancreatic malignancy using antibodies for apolipoprotein-AII isoforms |
title | Plasma biomarker for detection of early stage pancreatic cancer and risk factors for pancreatic malignancy using antibodies for apolipoprotein-AII isoforms |
title_full | Plasma biomarker for detection of early stage pancreatic cancer and risk factors for pancreatic malignancy using antibodies for apolipoprotein-AII isoforms |
title_fullStr | Plasma biomarker for detection of early stage pancreatic cancer and risk factors for pancreatic malignancy using antibodies for apolipoprotein-AII isoforms |
title_full_unstemmed | Plasma biomarker for detection of early stage pancreatic cancer and risk factors for pancreatic malignancy using antibodies for apolipoprotein-AII isoforms |
title_short | Plasma biomarker for detection of early stage pancreatic cancer and risk factors for pancreatic malignancy using antibodies for apolipoprotein-AII isoforms |
title_sort | plasma biomarker for detection of early stage pancreatic cancer and risk factors for pancreatic malignancy using antibodies for apolipoprotein-aii isoforms |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4637825/ https://www.ncbi.nlm.nih.gov/pubmed/26549697 http://dx.doi.org/10.1038/srep15921 |
work_keys_str_mv | AT hondakazufumi plasmabiomarkerfordetectionofearlystagepancreaticcancerandriskfactorsforpancreaticmalignancyusingantibodiesforapolipoproteinaiiisoforms AT kobayashimichimoto plasmabiomarkerfordetectionofearlystagepancreaticcancerandriskfactorsforpancreaticmalignancyusingantibodiesforapolipoproteinaiiisoforms AT okusakatakuji plasmabiomarkerfordetectionofearlystagepancreaticcancerandriskfactorsforpancreaticmalignancyusingantibodiesforapolipoproteinaiiisoforms AT rinaudojoann plasmabiomarkerfordetectionofearlystagepancreaticcancerandriskfactorsforpancreaticmalignancyusingantibodiesforapolipoproteinaiiisoforms AT huangying plasmabiomarkerfordetectionofearlystagepancreaticcancerandriskfactorsforpancreaticmalignancyusingantibodiesforapolipoproteinaiiisoforms AT marshtracey plasmabiomarkerfordetectionofearlystagepancreaticcancerandriskfactorsforpancreaticmalignancyusingantibodiesforapolipoproteinaiiisoforms AT sanadamitsuaki plasmabiomarkerfordetectionofearlystagepancreaticcancerandriskfactorsforpancreaticmalignancyusingantibodiesforapolipoproteinaiiisoforms AT sasajimayoshiyuki plasmabiomarkerfordetectionofearlystagepancreaticcancerandriskfactorsforpancreaticmalignancyusingantibodiesforapolipoproteinaiiisoforms AT nakamorishoji plasmabiomarkerfordetectionofearlystagepancreaticcancerandriskfactorsforpancreaticmalignancyusingantibodiesforapolipoproteinaiiisoforms AT shimaharamasashi plasmabiomarkerfordetectionofearlystagepancreaticcancerandriskfactorsforpancreaticmalignancyusingantibodiesforapolipoproteinaiiisoforms AT uenotakaaki plasmabiomarkerfordetectionofearlystagepancreaticcancerandriskfactorsforpancreaticmalignancyusingantibodiesforapolipoproteinaiiisoforms AT tsuchidaakihiko plasmabiomarkerfordetectionofearlystagepancreaticcancerandriskfactorsforpancreaticmalignancyusingantibodiesforapolipoproteinaiiisoforms AT satanaohiro plasmabiomarkerfordetectionofearlystagepancreaticcancerandriskfactorsforpancreaticmalignancyusingantibodiesforapolipoproteinaiiisoforms AT iokatatsuya plasmabiomarkerfordetectionofearlystagepancreaticcancerandriskfactorsforpancreaticmalignancyusingantibodiesforapolipoproteinaiiisoforms AT yasunamiyohichi plasmabiomarkerfordetectionofearlystagepancreaticcancerandriskfactorsforpancreaticmalignancyusingantibodiesforapolipoproteinaiiisoforms AT kosugetomoo plasmabiomarkerfordetectionofearlystagepancreaticcancerandriskfactorsforpancreaticmalignancyusingantibodiesforapolipoproteinaiiisoforms AT miuranami plasmabiomarkerfordetectionofearlystagepancreaticcancerandriskfactorsforpancreaticmalignancyusingantibodiesforapolipoproteinaiiisoforms AT kamitamasahiro plasmabiomarkerfordetectionofearlystagepancreaticcancerandriskfactorsforpancreaticmalignancyusingantibodiesforapolipoproteinaiiisoforms AT sakamototakako plasmabiomarkerfordetectionofearlystagepancreaticcancerandriskfactorsforpancreaticmalignancyusingantibodiesforapolipoproteinaiiisoforms AT shojihirokazu plasmabiomarkerfordetectionofearlystagepancreaticcancerandriskfactorsforpancreaticmalignancyusingantibodiesforapolipoproteinaiiisoforms AT junggiman plasmabiomarkerfordetectionofearlystagepancreaticcancerandriskfactorsforpancreaticmalignancyusingantibodiesforapolipoproteinaiiisoforms AT srivastavasudhir plasmabiomarkerfordetectionofearlystagepancreaticcancerandriskfactorsforpancreaticmalignancyusingantibodiesforapolipoproteinaiiisoforms AT yamadatesshi plasmabiomarkerfordetectionofearlystagepancreaticcancerandriskfactorsforpancreaticmalignancyusingantibodiesforapolipoproteinaiiisoforms |